NAGLAZYME
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68135-020 -
Package NDC
68135-020-01 -
Application number
BLA125117 -
SPL ID
02482a8a-8333-4e9c-a9dc-ff7780f40363 -
SPL set ID
59341250-deac-ed71-3823-a4f5d64dbd77 -
UNII
59UA429E5G -
RxCUI
578037 -
RxCUI
584222
What the source publishes
- Labeler
- BioMarin Pharmaceutical Inc.
- Active ingredients
- galsulfase
- Form
- SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NAGLAZYME",
"splId": "02482a8a-8333-4e9c-a9dc-ff7780f40363",
"labels": [
{
"setId": "59341250-deac-ed71-3823-a4f5d64dbd77",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59341250-deac-ed71-3823-a4f5d64dbd77",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=59341250-deac-ed71-3823-a4f5d64dbd77"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "BioMarin Pharmaceutical Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (68135-020-01) / 5 mL in 1 VIAL",
"package_ndc": "68135-020-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20050609"
}
],
"productId": "68135-020_02482a8a-8333-4e9c-a9dc-ff7780f40363",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "68135-020",
"deaSchedule": null,
"genericName": "galsulfase",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GALSULFASE",
"strength": "5 mg/5mL"
}
],
"applicationNumber": "BLA125117",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20050609",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0000794",
"N0000175823"
],
"unii": [
"59UA429E5G"
],
"rxcui": [
"578037",
"584222"
],
"spl_set_id": [
"59341250-deac-ed71-3823-a4f5d64dbd77"
],
"pharm_class_cs": [
"alpha-Glucosidases [CS]"
],
"pharm_class_epc": [
"Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]"
],
"manufacturer_name": [
"BioMarin Pharmaceutical Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68135-020_02482a8a-8333-4e9c-a9dc-ff7780f40363"